Wetterwald

VAD or VMBCP in multiple myeloma refractory to or relapsing after cyclophosphamide–prednisone therapy (protocol MY 85)

Bernard, Michaux, Laporte, 1998, British journal of haematology.

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Augustin Ferrant, Chantal Doyen, J. Rossi, 2006 .

Clinical Trials and Observations

C. Bloomfield, L. Staudt, A. Rosenwald, 2005 .